ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways

Xie, Baocheng; Zeng, Zhanwei; Liao, Shiyi; Zhou, Chenhui; Wu, Longhuo*; Xu, Daohua*广东医学院; 南方医科大学
Frontiers in Pharmacology2021-10-5DOI: 10.3389/fphar.2021.739326
23被引6阅读
引用收藏
分享

摘要

Kaempferol has been reported to exhibit beneficial effect on the osteogenic differentiation in mesenchymal stem cells (MSC) and osteoblasts. In our previous study, dexamethasone (DEX) demonstrated inhibitory effect on MC3T3-E1 cells differentiation. In this study, we mainly explored the protective effect of kaempferol on the inhibitory activity of DEX in the osteogenesis of MC3T3-E1 cells. We found that kaempferol ameliorated the proliferation inhibition, cell cycle arrest, and cell apoptosis and increased the activity of alkaline phosphatase (ALP) and the mineralization in DEX-treated MC3T3-E1 cells. Kaempferol also significantly enhanced the expression of osterix (Osx) and runt-related transcription factor 2 (Runx2) in MC3T3-E1 cells treated with DEX. In addition, kaempferol attenuated DEX-induced reduction of cyclin D1 and Bcl-2 expression and elevation of p53 and Bax expression. Kaempferol also activated JNK and p38-MAPK pathways in DEX-treated MC3T3-E1 cells. Furthermore, kaempferol improved bone mineralization in DEX-induced bone damage in a zebrafish larvae model. These data suggested that kaempferol ameliorated the inhibitory activity of DEX in the osteogenesis of MC3T3-E1 cells by activating JNK and p38-MAPK signaling pathways. Kaempferol exhibited great potentials in developing new drugs for treating glucocorticoid-induced osteoporosis.

学科与关键词

关键词
kaempferolosteogenic differentiationdexamethasoneosteoporosisJNK and p38 MAPK signaling pathways
相关
加载中…
  • Epimedin C Alleviates Glucocorticoid-Induced Suppression of Osteogenic Differentiation by Modulating PI3K/AKT/RUNX2 Signaling Pathway
    Xu, Yongxiang; Chen, Shichun; Huang, Linxuan; Han, Weichao; Shao, Yingying; Chen, Minyi; Zhang, Yusheng; He, Ruirong*; Xie, Baocheng*Frontiers in Pharmacology, 2022, 13: 894832.被引 4
  • Effect of Kaempferol on the Viability and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Aging Rats
    Tang, Shenghui*; Zuo, Junhua; Zhang, Haonan; Wu, Songsong; Liang, Biru*JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37(5): 2561-2567.
  • Salidroside alleviates dexamethasone-induced inhibition of bone formation via transforming growth factor-beta/Smad2/3 signaling pathway
    Xie, Baocheng; Zhou, Huan; Liu, Hongyu; Liao, Shiyi; Zhou, Chenhui; Xu, Daohua*Phytotherapy Research, 2023, 37(5): 1938-1950.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-10-05
卷期
第 12 卷
页码
739326
DOI
10.3389/fphar.2021.739326
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Discipline construction project of Guangdong Medical University [4SG21002G]; National Natural Science Foundation of China [82000842, 82060407]; Guangdong Basic and Applied Basic Research Foundation [2021A1515010151]; Dongguan Science and technology of social development Program [202050715001197]

作者

  • X

    Xie, Baocheng (第一作者)

    southern med univ · guangdong med univ

  • Z

    Zeng, Zhanwei

    guangdong med univ · new

查看全部 6 位作者收起作者
  • L

    Liao, Shiyi

    guangdong med univ · new

  • Z

    Zhou, Chenhui

    guangdong med univ

  • W

    Wu, Longhuo (通讯)

    gannan med univ

  • X

    Xu, Daohua (通讯)

    guangdong med univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417